Healthpeak Properties, Inc. (DOC) earnings on August 4, 2026
More Healthpeak Properties, Inc. earnings
Prior outlook: Pessimistic Outcome: Missed
Healthpeak Properties' stock rose 1.25% after its earnings report, despite a prior negative outlook. The company's quarterly numbers beat estimates and it raised its future outlook.
DOC price around the earnings
21.79
Change: +0.8%
2026-08-05, 20:00 UTC
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- No trading (market closed)
- Starting price
Prior thesis
Prior outlook: Pessimistic Outcome: Missed
- Thesis published
- Results released
Negative trend strength and trajectory collapse, but strategic JV with Brookfield provides fundamental support.
Context analyzed before publication
- Trend
- Significant cool-off and negative trend strength into earnings, with conservative analyst targets.
Analysts
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 2.41
- Analysts covering the stock
- 19
- Average price target
- 22.39
- Lowest price target
- 17
- Highest price target
- 29
- Upside to price target
- 3.8%
- Quarterly earnings growth
- 352.1%
- Revenue growth
- 7.1%
- Forward EPS
- -0.15
- Trailing EPS
- 0.32
- Analyst moves in the last 60 days
- 7
- Strong buy: 3
- Buy: 5
- Hold: 14
- Sell: 0
- Strong sell: 0
- Strong buy
- 3
- Buy
- 5
- Hold
- 14
- Sell
- 0
- Strong sell
- 0
- July 15, 2026 · Wells Fargo: Maintains rating (Equal-Weight → Equal-Weight)
- July 8, 2026 · UBS: Maintains rating (Neutral → Neutral)
- July 7, 2026 · Barclays: Initiates coverage (Overweight → Equal-Weight)
- July 6, 2026 · Mizuho: Maintains rating (Outperform → Outperform)
- June 24, 2026 · JP Morgan: Maintains rating (Neutral → Neutral)
- June 15, 2026 · BMO Capital: Maintains rating (Outperform → Outperform)
- June 11, 2026 · Morgan Stanley: Downgrades rating (Overweight → Equal-Weight)
News and sentiment
Evidence
Sentiment
- Sentiment
- Neutral
- Mention volume
- High
- Normalized volume
- 99%
News
Sources (5)
- Healthpeak Properties And Brookfield Asset Management Form $2.1B Long-Term Strategic Capital JV Involving Portfolio Of Outpatient Medical Buildings Across US (opens in a new tab) — Benzinga
- Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $22 (opens in a new tab) — Benzinga
- UBS Maintains Neutral on Healthpeak Properties, Raises Price Target to $21.5 (opens in a new tab) — Benzinga
- Barclays Initiates Coverage On Healthpeak Properties with Equal-Weight Rating, Announces Price Target of $23 (opens in a new tab) — Benzinga
- Mizuho Maintains Outperform on Healthpeak Properties, Raises Price Target to $24 (opens in a new tab) — Benzinga
Technicals
Evidence
- Price when the context was analyzed
- 21.65
- Average true range (ATR)
- 2%
- Distance to 52-week high
- -5.4%
- 14-day change (14d)
- -2.9%
- 30-day change (32d)
- -1.0%
- 30-day relative strength
- -2.7%
- SPY change (32d)
- +1.7%
- Nearest support
- 21.56
- Distance to nearest support
- 0.4%
- Nearest resistance
- 21.66
- Distance to nearest resistance
- 0.1%
- Volume accumulation ratio (14d / 46d)
- 0.91
- Major: 21.56 (0.4% away, 0.21 ATR, 24 touches)
- Minor: 21.38 (1.3% away, 0.63 ATR, 7 touches)
- Major: 21.27 (1.8% away, 0.88 ATR, 27 touches)
- Major: 21.66 (0.1% away, 0.02 ATR, 30 touches)
- Major: 21.91 (1.2% away, 0.6 ATR, 35 touches)
- Major: 22.11 (2.1% away, 1.05 ATR, 27 touches)
Trends
Evidence
- Average earnings surprise
- +7.9%
- May 5, 2026: actual EPS 0.28 vs estimate 0.06 (surprise +363.1%)
- February 2, 2026: actual EPS 0.1 vs estimate 0.06 (surprise +59.3%)
- October 23, 2025: actual EPS -0.18 vs estimate 0.06 (surprise -403.2%)
- July 24, 2025: actual EPS 0.06 vs estimate 0.06 (surprise +12.2%)
Expected move
- Implied move
- +1.7%
- Source
- Options chain
Reactions over its last 20 earnings
- Median move
- 2.5%
- 75th percentile move
- 3.5%
- 90th percentile move
- 5.6%
- Up / down moves
- 7 / 13
- Average up move
- +4.8%
- Average down move
- -2.6%
Monitoring and close
What Healthpeak Properties, Inc. reported
- Status
- Finished
| Actual EPS | 0.46 |
|---|---|
| EPS estimate | 0.44 |
| EPS surprise | +4.5% |
| Revenue | $772 million |
| Revenue estimate | $720 million |
| Revenue surprise | +7.2% |
Healthpeak Properties beat Q2 expectations with FFO of $0.46 per share and revenue of $771.6M. The company raised its FY2026 FFO guidance, reflecting optimism.
Sources (4)
- Healthpeak (DOC) Surpasses Q2 FFO and Revenue Estimates (opens in a new tab) — Zacks
- Healthpeak Properties beat expectations with FFO of $0.46 per share versus $0.44 estimated. Revenue of $771.6M also exceeded the $719.6M forecast. — Benzinga
- Healthpeak Properties Q2 FFO $0.46 Beats $0.44 Estimate, Sales $771.579M Beat $719.583M Estimate (opens in a new tab) — Benzinga
- Healthpeak Properties Raises FY2026 FFO Guidance from $1.71-$1.75 to $1.73-$1.77 vs $1.74 Est (opens in a new tab) — Benzinga
Pre-market second reading after the results
- Verdict
- Beat expectations
Heading into the open, the results beat expectations on both earnings and revenue, and the price is indicating +2.0% pre-market, a move in line with the stock's usual reaction (about 2%). The figures don't confirm the prior scenario: the comparable cases aren't consistent enough.
How the stock reacted
- Outcome
- Missed
- Consolidated
- +1.3%
- Max favorable move (MFE)
- 0.2%
- Max adverse move (MAE)
- 3.8%